← Open Payments lookup

SARBJIT SINGH: Open Payments

NPI 1184293490 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,593 in 93 payments from 13 companies in 2025. Trend: 2023 $1,626 · 2024 $1,817 · 2025 $1,593

Food & beverage: $1,593
CompanyPaymentsAmount
ABBVIE INC.36$557
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$300
Alkermes, Inc.10$183
Lundbeck LLC9$166
Otsuka America Pharmaceutical, Inc.5$117
Takeda Pharmaceuticals U.S.A., Inc.3$56
Vanda Pharmaceuticals Inc.3$56
Neurocrine BioSciences, Inc.3$53
Axsome Therapeutics, Inc.2$31
E.R. Squibb & Sons, L.L.C.1$21

Products named: VRAYLAR, CAPLYTA, REXULTI, ARISTADA, TRINTELLIX, FANAPT, INGREZZA, ABILIFY ASIMTUFII.

Industry payments across AZ — which companies pay providers there.